Search Results 61-70 of 8322 for imiquimod

  1. Avapritinib (oral route) - Side effects & dosage - Mayo Clinic

    Description. Avapritinib is used to treat a certain type of stomach, bowel, or esophagus cancer called gastrointestinal stromal tumor (GIST) that cannot be ...

  2. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them or carry cancer- ...

  3. Defactinib Combined With Pembrolizumab And Gemcitabine In Patients With Advanced Cancer - Mayo Clinic

    About this study. In pancreatic cancer, targeting the tumor microenvironment has become a promising therapeutic strategy. Focal adhesion kinase (FAK) ...

  4. Idarubicin (intravenous route) - Side effects & uses - Mayo Clinic

    Idarubicin injection is used in combination with other medicines to treat acute myeloid leukemia (AML). Idarubicin belongs to the group of medicines known as ...

  5. Adding The Immunotherapy Drug Cemiplimab To Usual Treatment For People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy And Immunotherapy (An Expanded Lung-MAP Treatment Trial) - Mayo Clinic

    Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Ramucirumab is a monoclonal antibody ...

  6. Pemigatinib (oral route) - Side effects & dosage - Mayo Clinic

    Pemigatinib is also used to treat myeloid/lymphoid neoplasms (blood cancer) that has come back or did not respond to treatment in patients who have a certain ...

  7. Program For Pembrolizumab (MK-3475) In Participants With Metastatic Melanoma Who Have Failed Standard Of Care Therapy Including Ipilimumab (MK-3475-030) - Mayo Clinic

    This is an expanded access program (EAP) for participants who have progressed after prior systemic therapy including ipilimumab, and V-raf murine sarcoma viral ...

  8. Biological Therapy For Cancer Clinical Trials - Mayo Clinic Research

    This study will test a study drug called cemiplimab to see if it can help treat early-stage Cutaneous Squamous Cell Carcinoma (CSCC), a type of skin cancer.

  9. Ibritumomab (intravenous route) - Side effects & uses - Mayo Clinic

    Ibritumomab injection is a monoclonal antibody. It is used together with another monoclonal antibody (rituximab) and one radioactive medication (Y-90).

  10. Repotrectinib (oral route) - Side effects & dosage - Mayo Clinic

    Repotrectinib is used to treat ROS1-positive non-small cell lung cancer (NSCLC) that has spread within your chest or to other parts of the body. Your doctor ...